ENOXAPARINE TEVA 4000 IU (40 mg)/0.4 ml, solution for injection in a pre-filled syringe 6 syringes of 0.4 ml
Active ingredients: ÉNOXAPARINE SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection6 syringes of 0.4 mlintraveineuse;sous-cutanée;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENOXAPARINE TEVA 4000 UI (40 mg)/0,4 mL, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée;voie extracorporelle autre
- Presentation description
- 6 seringue(s) préremplie(s) en verre de 0,4 mL
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
63065634CIP73024176CIP133400930241769Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉNOXAPARINE SODIQUEsolution | 40 mg · une seringue préremplie de 0,4 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.